Watchlist Price Alert

Lantern Pharma Inc. (LTRN)

NASDAQ: LTRN · Real-Time Price · USD

3.99

-0.07 (-1.72%)

At close: May 15, 2025, 9:42 AM

Lantern Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	7.51M	21.94M	37.2M	51.52M	19.23M	1.23M	445.16K
Short-Term Investments	16.5M	19.36M	17.99M	19.2M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	1M	n/a	n/a	n/a
Other Long-Term Assets	36.74K	25.87K	17.89K	17.89K	101.2K	191K	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	-592K	-181K	n/a	n/a	n/a
Other Current Assets	1.14M	1.61M	2.77M	n/a	n/a	n/a	n/a
Total Current Assets	25.25M	43.34M	58.72M	72.72M	20.24M	1.23M	445.16K
Property-Plant & Equipment	287.43K	280.42K	95.69K	216.19K	21.51K	8.76K	4.67K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	324.16K	306.29K	113.58K	1.23M	122.71K	199.76K	4.67K
Total Assets	25.57M	43.65M	58.84M	73.95M	20.36M	1.43M	449.83K
Account Payables	n/a	n/a	932.41K	681.11K	432.34K	478.29K	97.63K
Deferred Revenue	n/a	n/a	-2.75M	-2.17M	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	4.33B	2.51M	1.81M	1.49M	120K	2K	535K
Total Current Liabilities	4.33B	2.68M	2.8M	2.33M	552.34K	489.29K	651.63K
Long-Term Debt	n/a	n/a	n/a	n/a	108.5K	n/a	n/a
Other Long-Term Liabilities	52.79M	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	52.84M	61.5K	52.89K	52.89K	108.5K	n/a	n/a
Total Liabilities	4.38M	2.74M	2.8M	2.38M	660.84K	489.29K	651.63K
Total Debt	243.66K	234.47K	52.89K	204.95K	108.5K	n/a	n/a
Common Stock	1.08K	1.07K	1.09K	1.11K	622.00	11.37K	11.37K
Retained Earnings	-76.03B	-55.24M	-39.28M	-25.02M	-12.66M	-6.75M	-4.32M
Comprehensive Income	153.99K	-107.46K	-371.39K	-92.69K	-0.00	n/a	n/a
Shareholders Equity	21.19B	40.91M	56.04M	71.57M	19.7M	943.28K	-201.8K
Total Investments	16.5M	19.36M	17.99M	19.2M	n/a	n/a	n/a